11 November 2018
Trendlines Medical Singapore entered into a Memorandum of Understanding (MOU) with Accelerate Technologies (A*ccelerate) to collaborate and explore potential joint R&D initiatives in several medical technology areas.
Under the MOU, Trendlines Medical Singapore and A*ccelerate will work together to identify technology from A*STAR with the intention of spinning-off up to five start-up companies that will benefit from Trendlines Medical Singapore’s expertise in medical device incubation and A*ccelerate’s technology development capability.
Trendlines Medical Singapore and A*ccelerate have identified projects in the field of ultrasound-guided therapies, neurorehabilitation, radiology, ophthalmology, urology, and gastroenterology as areas of focus.
Trendlines Medical Singapore portfolio company Medulla Pro is developing its ultrasound-guided technology in partnership with A*ccelerate.
A*ccelerate is the commercialization arm of the Agency for Science, Technology and Research (A*STAR), Singapore’s lead agency for fostering world-class scientific research and talent.
FruitSpec raises $5 million
FruitSpec’s Yield Management Platform provides digital visibility of fruit yield data to entire supply-chain production units
Phytolon secures $4.1 million in funding
Funding for fermentation-based technology for the production of food colors